CoChat

PET staging of amyloidosis using striatum

Open access
Hanseeuw, Bernard J., Betensky, Rebecca A., Mormino, Elizabeth C., Schultz, Aaron P., Sepulcre, Jorge, Becker, John A., Jacobs, Heidi I.L., Buckley, Rachel F., LaPoint, Molly R., Vannini, Patrizia, Donovan, Nancy J., Chhatwal, Jasmeer P., Marshall, Gad A., Papp, Kathryn V., Amariglio, Rebecca E., Rentz, Dorene M., Sperling, Reisa A., Johnson, Keith A., for the Alzheimer's Disease Neuroimaging Initiative, and the Harvard Aging Brain Study · 2018 · Alzheimer's & Dementia
Cited by 130

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Introduction: Amyloid positron emission tomography (PET) data are commonly expressed as binary measures of cortical deposition. However, not all individuals with high cortical amyloid will experience rapid cognitive decline. Motivated by postmortem data, we evaluated a three‐stage PET classification: low cortical; high cortical, low striatal; and high cortical, high striatal amyloid; hypothesizing this model could better reflect Alzheimer's dementia progression than a model based only on cortical measures. Methods: We classified PET data from 1433 participants (646 normal, 574 mild cognitive impairment, and 213 AD), explored the successive involvement of cortex and striatum using 3‐year follow‐up PET data, and evaluated the associations between PET stages, hippocampal volumes, and cognition. Results: Follow‐up data indicated that PET detects amyloid first in cortex and then in striatum. Our three‐category staging including striatum better predicted hippocampal volumes and subsequent cognition than a three‐category staging including only cortical amyloid. Discussion: PET can evaluate amyloid expansion from cortex to subcortex. Using striatal signal as a marker of advanced amyloidosis may increase predictive power in Alzheimer's dementia research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2018.04.011

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 20

  1. 10.1186/s40478-016-0399-z · DOI · Paper page
  2. 10.3233/JAD-150732 · DOI
  3. 10.1212/WNL.0000000000001209 · DOI · Paper page
  4. 10.1212/WNL.0b013e3182563bbe · DOI · Paper page
  5. 10.1016/j.jalz.2013.11.005 · DOI · Paper page
  6. 10.1016/j.neurobiolaging.2016.08.017 · DOI
  7. 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
  8. 10.1016/j.jalz.2017.01.018 · DOI · Paper page
  9. 10.1007/s11682-012-9186-z · DOI · Paper page
  10. 10.1007/s11682-012-9176-1 · DOI · Paper page
  11. 10.2967/jnumed.114.148981 · DOI · Paper page
  12. 10.2967/jnumed.112.109009 · DOI · Paper page
  13. Ard M.C., 2011, Power calculations for clinical trials in Alzheimer's disease, J Alzheimers Dis, 26, 369, 10.3233/JAD-2011-0062 · DOI · Paper page
  14. 10.1016/S1474-4422(15)00323-3 · DOI · Paper page
  15. 10.1126/scitranslmed.3007941 · DOI · Paper page
  16. 10.1001/archneurol.2009.285 · DOI · Paper page
  17. 10.1016/j.jalz.2011.09.229 · DOI · Paper page
  18. 10.1212/WNL.0000000000000431 · DOI · Paper page
  19. Dugger B.N., 2012, Presence of striatal amyloid plaques in Parkinson's Disease dementia predicts concomitant Alzheimer's disease: usefulness for amyloid imaging, J Parkinsons Dis, 2, 57, 10.3233/JPD-2012-11073 · DOI · Paper page
  20. 10.1212/WNL.0000000000000721 · DOI · Paper page

Cited by

See all 130

Metadata

Authors
Hanseeuw, B. J., Betensky, R. A., Mormino, E. C., Schultz, A. P., Sepulcre, J., Becker, J. A., Jacobs, H. I. L., Buckley, R. F., LaPoint, M. R., Vannini, P., Donovan, N. J., Chhatwal, J. P., Marshall, G. A., Papp, K. V., Amariglio, R. E., Rentz, D. M., Sperling, R. A., Johnson, K. A., Initiative, F. T. A. D. N., & Study, A. T. H. A. B.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2018-05-21
Volume
14
Issue
10
Pages
1281-1292
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2803295480
Cited by
130
References
16
FWCI
10.06
Type
journal article
Language
en
Open access
hybrid
Funders
  • Alzheimer's Association
  • Harvard NeuroDiscovery Center
  • Fidelity Biosciences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PET staging of amyloidosis using striatum. https://app.cochat.ai/papers/10.1016/j.jalz.2018.04.011
The paper
Hanseeuw, B. J., Betensky, R. A., Mormino, E. C., Schultz, A. P., Sepulcre, J., Becker, J. A., Jacobs, H. I. L., Buckley, R. F., LaPoint, M. R., Vannini, P., Donovan, N. J., Chhatwal, J. P., Marshall, G. A., Papp, K. V., Amariglio, R. E., Rentz, D. M., Sperling, R. A., Johnson, K. A., Initiative, F. T. A. D. N., & Study, A. T. H. A. B. (2018). PET staging of amyloidosis using striatum. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2018.04.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.